Parkinsons Disease Drugs Flashcards

(47 cards)

1
Q

What is Parkinson’s disease

A

Progressive disabling neurodegenerative disorder of movement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Main reason of Parkinson’s disease

A

Gradual loss of neurons in the substantia nigra of the brain. So loss of dopamine which coordinate movements

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Clinical features of Parkinson’s diseases

A

Tremor
rigidity
bradykinesia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Two forms of Parkinson’s disease

A

Idiopathic Parkinson disease with unknown cause

Iatrogenic Parkinson disease drug induced

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What type of drugs can cause Parkinson’s disease

A

Antipsychotic drugs like butyrophenone and phenothiazines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Genes involved in Parkinson’s disease

A
Alpha synuclein
Parkin 
Glucocerebrosidase
PINK1
LRRK2
DJ1
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Is there a cure for parkinsonism

A

No

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Drugs type that good provides relief in Parkinson’s disease

A

Levodopa
Dopamine agonists
Mono amine oxidase inhibitors
Anticholinergic agents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Most reliable and effective drug in Parkinson’s disease

A

Levodopa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Mechanism of action of levodopa

A

Precursor of dopamine which innovate dopamine level

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Why is dopamine not administered directly but rather through levodopa’s

A

Because cannot cross the blood brain barrier contrary to level

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Metabolism of levodopa

A

Amino acid decarboxylase in the liver kidney and GHT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How do we prevent metabolism of levodopa

A

By coadministering carbidopa or benserazide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Can food delay the appearance of levodopa in the plasma

A

Yes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

When do you think the best results of levodopa treatment

A

In the first three or four years of therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Adverse effects of levodopa

A

Anorexia nausea vomiting so should divide doses and take antacids and anti-emetics

Cardiac arrhythmias tachycardia ventricular extrasystole’s

Dyskinesias

Depression anxiety agitation insomnia somnolence confusion delusions hallucinations nightmares euphoria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are some miscellaneous adverse effects of levodopa

A
Mydriasis
Various blood dyscrasias
Hot flashes positive comes test 
precipitation of gout 
smell or taste abnormalities 
Priaprism 
blood urea nitrogen elevated
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Can you give levodopa to Patience taking MAO

A

No

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Can you give levodopa to psychotic patients

20
Q

Can you give liver to fly to patient with angle closure glaucoma

21
Q

Can you give levodopa to patient with active peptic ulcer

A

Yes but precaution

22
Q

What is the advantage of dopamin agonist compared to levodopa

A

Limited adverse effects
no potential toxic metabolites
no competition at the blood brain barrier no response fluctuations and dyskinesia

23
Q

Examples of dopamine agonist

A
Bromocriptine
Pergolide
Pramipexole
 Ropinirole
Rotigotine
Apomorphine
24
Q

Drug used to treat Parkinson’s disease and hyperprolactinemia

25
Receptor stimulated by bromocriptine
D2
26
Receptor stimulated by pergolide
D1 D2
27
In which way is percolate more effective than bromocriptine
Relieving symptoms and signs of Parkinson’s disease increasing on-time response from response fluctuators permitting levodopa dose s to be reduced
28
Pramipexole act on which receptor
D3
29
When is pramipexole effective
When used as a single agent for mild Parkinson. So used in advanced disease to reduce levodopa
30
Ropinirole Acton which receptor
D2
31
When do you use ropinirole
Does Moov in response to levodopa in More advanced disease
32
How do you administer rotigotine
Transdermal patch
33
How do you administer Apomorphine
IV injection
34
Dopamine agonist adverse effects
``` Anorexia nausea vomiting constipation dyspepsia reflux oesophagitis s bleeding from peptic ulcer confusion hallucination delusions postural hypotension painless digital vasospasm cardiac arrhythmias peripheral edema ```
35
Miscellaneous effect of dopamine agonist
``` Headache nasal congestion increased arousal pulmonary infiltrates Pleural and retroperitoneal fibrosis erythromelalgia Narcolepsy ```
36
Contra indications of dopamine agonist
Psychotic illness recent myocardial infarction active peptic ulcer ration ergot derived agonist avoided in peripheral vascular disease
37
Which monoamine oxidase inhibitors are used in Parkinson’s disease treatment
The one that ACT on MAO B Which is the one concerned with metabolism of dopamine Selegiline Rasagiline
38
When should you give selegiline
When declined fluctuating response to levodopa
39
Should not give these drugs with selegeline
Pethidine TCAs serotonin reuptake inhibitors
40
Which is more potent , selegiline or rasagiline
Rasagiline
41
Can you give both MAO and levodopa
No risk of hypertensive crisis
42
How do drugs part of the catechol o methyltransferase inhibitors help
Prevent competition 3OMD with levodopa for active carrier mechanism
43
Selective COMT USED
Tolcapone | Entacapone
44
When can you give COMT inhibitors
Response fluctuations with levodopa
45
Viral agent used for Parkinson disease
Amantadine
46
Acetylcholine blocking drugs examples
``` Benztropine mesylate Biperiden Orphenadrine Procyclidine Trihexyphenidyl ```
47
Can you use antihistamine diphenhydramine as anticholinergic agent for mild Parkinson patient who can’t tolerate anything else
Yes